US$ 22.48
is wegovy a glp-1 drug Compare Options | Ozempic v Mounjaro | WeightWatchers Early uptake of Wegovy pill
Description
Less clear is how GLP-1s will influence other industries, from adjacencies like medical device technology to downstream sectors like food and beverage

From Medicaid data publicly available, there is no way yet to disentangle how much of the growing use of GLP-1s is related to treatment for diabetes, cardiovascular disease, or sleep apnea versus obesity, or a combination

As The New Yorker has observed, the rise of GLP-1s marks a shift not only in medicine but in cultureas appetite-modulating drugs move from treating diabetes toward shaping body ideals, identity, and social aspiration
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Meanwhile, among the current market leaders, Novo screens as the most attractive from a valuation and ESG risk perspective